Tolerability of anastrozole (A) compared with tamoxifen (T): Mature data in the adjuvant setting - Data reported on behalf of the ATAC ('arimidex', tamoxifen, alone or in combination) trialists' group

被引：0

作者：

Mansel, Robert ^{[1
]}

机构：

[1] Univ Wales Hosp, Dept Surg, Cardiff, Wales

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：94 / 94

页数：1

共 50 条

[1] Initial adjuvant therapy with anastrozole (A) reduces rates of early breast cancer recurrence and adverse events compared with tamoxifen (T) - Data reported on behalf of the ATAC('arimidex', tamoxifen, alone or in combination) trialists' group
Houghton, Joan
ANNALS OF ONCOLOGY, 2006, 17 : 94 - 94
[2] Association between prior chemotherapy and the adverse event profile of adjuvant anastrozole and tamoxifen: a retrospective analysis of data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trail on behalf of the ATAC Trialists' Group
Coleman, Robert
ANNALS OF ONCOLOGY, 2004, 15 : 64 - 64
[3] Impact of age on gynaecological adverse events: data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial on behalf of the ATAC Trialists' Group
Disller, Wolfgang
ANNALS OF ONCOLOGY, 2004, 15 : 64 - 65
[4] Anastrozole has a protective effect on the endometrium: data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial
Duffy, S.
Greenwood, M.
EJC SUPPLEMENTS, 2004, 2 (03): : 140 - 140
[5] Gynecological adverse events including hysterectomy with anastrozole tamoxifen: Data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial.
Duffy, S
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 58S - 58S
[6] Maturity of data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial
Bianco, A. R.
EJC SUPPLEMENTS, 2005, 3 (02): : 99 - 99
[7] The endometrial cancer data from the ATAC (arimidex, tamoxifen, alone or in combination) trial indicates a protective effect of anastrozole (arimidex) upon the endometrium
Duffy, SR
Greenwood, M
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S29 - S29
[8] ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial-anastrozole is superior to tamoxifen as adjuvant treatment in postmenopausal women with early breast cancer.
Bianco, R
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S155 - S155
[9] Impact of age on the gynecologic adverse event (AE) profile of anastrozole (A) or tamoxifen (T) in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial.
Distler, W
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 69S - 69S
[10] Beneficial side-effect profile of anastrozole compared with tamoxifen confirmed by additional 7 months of exposure data: a safety update from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial
Sainsbury, R
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156

← 1 2 3 4 5 →